OSTX
Healthcare BiotechnologyOS Therapies Incorporated
$1.62
+0.00 +0.00% today
Price History
Not enough data
Key Stats
Market Cap
75.82M
Avg Volume
570,895
EPS
-$1.09
52W High
$2.25
52W Low
$1.15
Div. Yield
0.0%
Analyst Ratings
Buy1
Str Buy
3
Buy
0
Hold
0
Sell
0
Str Sell
Valuation
Forward P/E
4.67
P/B Ratio
-6.16
EV/EBITDA
-2.04
Margins
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Return on Assets
(232.7%)
Liquidity & Leverage
Current Ratio
0.18
Quick Ratio
0.16
Total Cash
205,035
Total Debt
0
About
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.
ostherapies.com